Radicals Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 23-10-2024
- Paid Up Capital ₹ 3.49 M
as on 23-10-2024
- Company Age 38 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.45 M
as on 23-10-2024
- Satisfied Charges ₹ 3.42 M
as on 23-10-2024
- Revenue 32.57%
(FY 2023)
- Profit 26.54%
(FY 2023)
- Ebitda 15.72%
(FY 2023)
- Net Worth 12.69%
(FY 2023)
- Total Assets 43.56%
(FY 2023)
About Radicals Pharma
The Corporate was formerly known as Radicals Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.49 M.
The company currently has active open charges totaling ₹3.45 M. The company has closed loans amounting to ₹3.42 M, as per Ministry of Corporate Affairs (MCA) records.
Mandeep Bhatia and Gurdeep Bhatia serve as directors at the Company.
- CIN/LLPIN
U24239HR1986PTC026450
- Company No.
026450
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 1986
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Radicals Pharma Private Limited offer?
Radicals Pharma Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antispasmodic Drugs, Digestive Drugs, Cardiovascular Drugs & Medication, Kidney Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Arthritic Drugs.
Who are the key members and board of directors at Radicals Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurdeep Bhatia  | Managing Director | 01-Apr-2006 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mandeep Bhatia | Whole-Time Director | 30-Sep-2009 | Current |
Financial Performance of Radicals Pharma.
Radicals Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.57% increase. The company also saw a substantial improvement in profitability, with a 26.54% increase in profit. The company's net worth Soared by an impressive increase of 12.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radicals Pharma?
In 2023, Radicals Pharma had a promoter holding of 60.32% and a public holding of 39.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 24 Apr 2024 | ₹0.75 M | Open |
Others Creation Date: 22 Jan 2021 | ₹2.70 M | Open |
Bank Of India Creation Date: 30 Apr 2012 | ₹0.70 M | Satisfied |
How Many Employees Work at Radicals Pharma?
Radicals Pharma has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radicals Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radicals Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
